How Rick Perry Became a Fervent Advocate for the Psychedelic Ibogainenews2025-08-11T18:19:05+00:00August 11th, 2025|The New York Times|
Top F.D.A. Official Resigns Under Pressurenews2025-07-30T02:59:00+00:00July 30th, 2025|The New York Times|
RFK Jr. Announces Plan to Restrict Opioid-Like Kratom Productnews2025-07-29T17:58:54+00:00July 29th, 2025|The New York Times|
Couple Whose Home Was Bursting With Illegal Sex Pills Are Sentencednews2025-07-25T21:10:21+00:00July 25th, 2025|The New York Times|
F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancynews2025-07-21T22:23:23+00:00July 21st, 2025|The New York Times|
Sarepta Refuses FDA Request to Stop Shipping Muscular Dystrophy Drug Elevidysnews2025-07-19T00:53:42+00:00July 19th, 2025|The New York Times|
Trump Administration’s N.I.H. and F.D.A. Cuts Could Curtail New Drug Development, Budget Office Saysnews2025-07-18T16:08:45+00:00July 18th, 2025|The New York Times|
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatmentsnews2025-07-17T21:48:42+00:00July 17th, 2025|The New York Times|
F.D.A. Posts Collection of Letters Outlining Concerns About New Drugsnews2025-07-10T21:42:29+00:00July 10th, 2025|The New York Times|
